Certara Launches Trial Simulator 2.3

Published on: 

Applied Clinical Trials

Certara, a provider of drug development, regulatory science, real-world evidence, and market access, announced the launch of version 2.3 of its Trial Simulator software in order to help drug developers improve clinical trial design by testing new ideas and evaluating trials for every phase of clinical drug development.

Read the full release here.